22 reports

  • Strategic Consolidations
  • Stage of development

Indian Journal of Pediatrics; ##(##): ##-## GW Pharmaceuticals (2017).

  • Clinical Trial
  • Genetic Disorder
  • Pharmaceutical
  • Therapy
  • Abeona Therapeutics, Inc.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • ABEONA THERAPEUTICS INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • ABEONA THERAPEUTICS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018

Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company focusing on the development and delivery of gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated...

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Abeona Therapeutics, Inc.
  • Active companies: Category and parameters
  • Introduction

You can easily book an appointment with one online.

  • Pharmaceutical
  • Therapy
  • United States
  • Abeona Therapeutics, Inc.
  • RegenxBio Inc.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES
  • MUCOPOLYSACCHARIDOSIS III (MPS III) (SANFILIPPO SYNDROME ) - PIPELINE BY ABEONA THERAPEUTICS INC, H1 2017

Axcentua Pharma is headquartered in Stockholm, Sweden.

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • ACCESS PHARMA ENTERS INTO LICENSING AGREEMENT WITH AMAG PHARMA FOR MUGARD
  • ACCESS PHARMA ENTERS INTO LICENSING AGREEMENT WITH HANMI PHARMA FOR MUGARD

Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company focusing on the development and delivery of gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated...

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Abeona Therapeutics, Inc.
  • Sales Comparisons (Most Recent Fiscal Year)
  • Financial Position

Abeona Therapeutics Inc operates within the Pharmaceutical preparations sector.

  • Pharmaceutical
  • Therapy
  • United States
  • Company Financials
  • Abeona Therapeutics, Inc.
  • MUCOPOLYSACCHARIDOSIS III (MPS III) (SANFILIPPO SYNDROME ) - PIPELINE BY ABEONA THERAPEUTICS INC, H2 2017
  • FEATURED NEWS & PRESS RELEASES

Axcentua Pharma is headquartered in Stockholm, Sweden.

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • VALUATION MULTIPLES (MACROCHEM CORP)
  • Target

It is headquartered COMPANY INFORMATION: PARTNERS PARTNER ##: AMAG PHARMACEUTICALS, INC.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Abeona Therapeutics, Inc.
  • ARMAGEN INC
  • PIPELINE BY ABEONA THERAPEUTICS INC, H2 2017

Esteve also develops, manufactures and markets active pharmaceutical ingredients (APIs) and advanced intermediates for the global pharmaceutical industry.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • BATTEN DISEASE - PIPELINE BY ABEONA THERAPEUTICS INC, H2 2017
  • ABEONA THERAPEUTICS INC

BATTEN DISEASE - PIPELINE BY ABEONA THERAPEUTICS INC, H## 2017 EVOTEC AG BATTEN DISEASE - PIPELINE BY EVOTEC AG, H## 2017 IONIS PHARMACEUTICALS INC Ionis Pharmaceuticals Inc (Ionis) formerly ISIS Pharmaceuticals, Inc. is clinical stage biopharmaceutical company.

  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • ARMAGEN INC
  • N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Companies Involved in Therapeutics Development

The company has partnership with AMAG Pharmaceuticals for the commercialization of its products in the US, Norgine B. V in European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia and New Zealand; RHEI Pharmaceuticals N. V in China; and Hanmi in South Korea.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • Products under Development by Companies
  • Fanconi Anemia - Pipeline by Abeona Therapeutics Inc, H1 2017

The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Blood Disease
  • Pharmaceutical
  • Turkey
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • VALUATION MULTIPLES (MACROCHEM CORPORATION)
  • VALUATION MULTIPLES (ABEONA THERAPEUTICS, INC. (FORMERLY PLASMATECH

PARTNER ##: AMAG PHARMACEUTICALS, INC.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Abeona Therapeutics, Inc.
  • PARTNERSHIP
  • Stanford University targets and partners (2014 -YTD2018)

STANFORD UNIVERSITY PARTNER ##: INTEGENX, INC.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Abeona Therapeutics, Inc.
  • BATTEN DISEASE - PIPELINE BY ABEONA THERAPEUTICS INC, H1 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

It collaborates with pharma and biotech companies for its research and development activities.

  • Dementia
  • Pharmaceutical
  • United States
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd